trending Market Intelligence /marketintelligence/en/news-insights/trending/tveusoeok3vuyc756lr6jg2 content esgSubNav
In This List

Device-maker Medartis prices Swiss IPO

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022

Blog

Insight Weekly: CEO pay jumps; yield curve inversion deepens; wind giants lift turbine prices


Device-maker Medartis prices Swiss IPO

Basel, Switzerland-based Medartis AG priced its IPO at CHF48 per share, in the middle of the indicated range of CHF44 per share to CHF54 per share, Reuters reported.

The pricing suggests a market capitalization of CHF563 million, plus a free float of 24.6%, including the overallotment option.

The medical device-maker will use gross proceeds of about CHF123.9 million, or CHF142.6 million including the overallotment shares, to fund its growth.

The shares will start trading on the SIX Swiss Exchange beginning March 23.

Medartis makes metal implants for the surgical fixation of bone fractures.